The role of opioid receptors in morphine withdrawal in the infant rat

Developmental Brain Research

Volumn 124, Issue 1-2, 2000, Pages 73-80

  McPhie, Anika A ^a,b   Barr, Gordon A ^a,b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

CTOP; Dependence; Naltrindole; Nor BNI; Opioid receptor; Withdrawal behavior

Indexed keywords

DELTA OPIATE RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR; MORPHINE SULFATE; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE;

ADOLESCENT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; MORPHINE ADDICTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ANIMALS; ANIMALS, NEWBORN; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, LONG-EVANS; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0034736088     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(00)00102-4     Document Type: Article

References (31)

1. κ Opioid receptor-mediated analgesia in the developing rat
2. Differential effects of specific opioid receptor agonists on rat pup isolation calls
3. Direct dependence studies in rats with agents selective for different types of opioid receptor
4. Ontogeny of μ-, δ-, and κ-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain
5. Fetal exposure to narcotics: Neonatal sleep as a measure of nervous system disturbance
6. The ontogeny of opiate tolerance and withdrawal in infant rats
7. Effects of maternal opiate abuse on the newborn
8. A simple technique for the permanent marking of newborn albino rats
9. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: An in situ hybridization study
10. Preclinical evidence for a role of glutamatergic systems in opioid tolerance and dependence
11. Ontogeny of morphine withdrawal in the rat
12. Postnatal development of multiple opioid receptors in rat brain
13. Differences in physical dependence induced by selective μ or δ opioid agonists and by endogenous enkephalins protected by peptidase inhibitors
14. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta, and kappa-selective opioid antagonists
15. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
16. Development of opioid systems: Peptides, receptors and pharmacology
17. Molecular mechanisms of drug addiction
18. The rat brain delta opioid receptor (ontogenic studies)
19. Methadone withdrawal in newborn infants
20. The prenatal developmental profile of expression of opioid peptides and receptors in the mouse brain
21. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal
22. Endogenous κ-opioid systems in opiate withdrawal: Role in aversion and accompanying changes in mesolimbic dopamine release
23. Magnitude of opioid dependence after continuous intrathecal infusion of μ- and δ-selective opioids in the rat
24. Interaction between mu and kappa receptors in pharmacological effects of tolerance to and dependence on several opioids
25. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine
26. Evidence for δ-opioid binding and gtp-regulatory proteins in 5-day-old rat brain membranes
27. Characterization of neonatal rat morphine tolerance and dependence
28. Opiate tolerance and dependence: Recent findings and synthesis
29. The ontogeny of mu opiate tolerance and dependence in the rat: Antinociceptive and biochemical studies
30. Comparison of abstinence syndromes following chronic administration of mu and kappa opioid agonists in the rat
31. Developmental expression of the μ, κ, and δ opioid receptor mRNAs in mouse